Rabu, Februari 2, 2022

Provisions on the Implementation of COVID-19 Booster Vaccinations Issued

In an attempt to make appropriate adjustments to the country’s COVID-19 vaccination program during the implementation of COVID-19 booster vaccinations ("Booster Vaccinations"), the Director-General of Disease Prevention and Control ("Director-General") has issued Letter No. SR.02.06/II/408/2022 ("Letter").
According to the new Letter, Booster Vaccinations for the general public may be rolled out simultaneously across all of Indonesia’s regencies/cities without the need to wait until the full-dose vaccination target of 70% and the single-dose vaccination target of 60% has been met for elderly citizens.
Citizens should meet the following requirements in order to receive Booster Vaccinations: 1) Must present Residency Identity Numbers (NIK) and bring their identity cards (i.e. KTP/family card) with them all, or use the PeduliLindungi app; 2) Must be a minimum of 18 years old; and 3) Must have received a complete first and second dose of COVID-19 vaccine ("Primary Dosage") a minimum of six months before receiving the third booster jab. Booster Vaccinations can be implemented through two mechanisms, specifically homolog (i.e. receiving the same type of vaccine as that administered during the Primary Dosage); or heterolog (i.e. receiving a different type of vaccine to that administered during the Primary Dosage).
The types of vaccines that will be used as boosters during the first quarter of 2022 break down as follows: 1) For citizens who received the Sinovac vaccine as their Primary Dosage: a) Half dose of Astra Zeneca; or b) Half dose of Pfizer; 2) For citizens who received the Astra Zeneca vaccine as their Primary Dosage: a) Half dose of Moderna; b) Half dose of Pfizer; or c) Full dose of Astra Zeneca.
The Letter has been in force since 27 January 2022.

......

Subscribe to read more legal analysis.

Hukumonline Pro Intelligence

Platform AI hukum terpercaya sebagai solusi komprehensif riset Anda

Professional Solutions

University Solutions

Pro

Rp 5.000.000 /bulan

Jadwalkan Demo

Lihat Detail

Pro AI

Terfavorit

Rp 8.200.000 /bulan

Jadwalkan Demo

Lihat Detail

Pro Compliance

New

Rp 12.500.000 /bulan

Jadwalkan Demo

Lihat Detail

*Syarat dan ketentuan berlaku

In an attempt to make appropriate adjustments to the country’s COVID-19 vaccination program during the implementation of COVID-19 booster vaccinations ("Booster Vaccinations"), the Director-General of Disease Prevention and Control ("Director-General") has issued Letter No. SR.02.06/II/408/2022 ("Letter").
According to the new Letter, Booster Vaccinations for the general public may be rolled out simultaneously across all of Indonesia’s regencies/cities without the need to wait until the full-dose vaccination target of 70% and the single-dose vaccination target of 60% has been met for elderly citizens.
Citizens should meet the following requirements in order to receive Booster Vaccinations: 1) Must present Residency Identity Numbers (NIK) and bring their identity cards (i.e. KTP/family card) with them all, or use the PeduliLindungi app; 2) Must be a minimum of 18 years old; and 3) Must have received a complete first and second dose of COVID-19 vaccine ("Primary Dosage") a minimum of six months before receiving the third booster jab. Booster Vaccinations can be implemented through two mechanisms, specifically homolog (i.e. receiving the same type of vaccine as that administered during the Primary Dosage); or heterolog (i.e. receiving a different type of vaccine to that administered during the Primary Dosage).
The types of vaccines that will be used as boosters during the first quarter of 2022 break down as follows: 1) For citizens who received the Sinovac vaccine as their Primary Dosage: a) Half dose of Astra Zeneca; or b) Half dose of Pfizer; 2) For citizens who received the Astra Zeneca vaccine as their Primary Dosage: a) Half dose of Moderna; b) Half dose of Pfizer; or c) Full dose of Astra Zeneca.
The Letter has been in force since 27 January 2022.

......